Gossamer Bio, Inc. (GOSS)
0.4249
+0.02
(+5.70%)
USD |
NASDAQ |
Feb 27, 16:00
0.413
-0.01
(-2.80%)
Pre-Market: 20:00
Gossamer Bio Research and Development Expense (TTM) : 161.14M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Vanda Pharmaceuticals, Inc. | 109.27M |
| Madrigal Pharmaceuticals, Inc. | 387.02M |
| XOMA Royalty Corp. | 2.295M |
| Rezolute, Inc. | 63.64M |
| Axsome Therapeutics, Inc. | 182.48M |